hims glp-1 states & Hers tackles high prices in Super Bowl ad The Unraveling of Hims' GLP-1
Description
Each escalation brings a temporary resurgence of GI symptoms as the body adjusts to the stronger gastric emptying delay
It is important to note that there is no definitive evidence establishing a permanent taste alteration with GLP-1 therapy, and individual experiences vary considerably
However, the FDA prescribing information includes a warning about acute kidney injury (AKI) in patients who experience severe gastrointestinal adverse reactions
At the suggestion of her endocrinologist, she started semaglutide in April 2022 and switched to tirzepatide after an insurance change, losing 41 pounds so far, and nearing her goal
[PubMed ID: 30001846]
Siener R, Glatz S, Nicolay C, Hesse A
